Crinetics Pharmaceuticals CRNX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's change in other assets?
- Crinetics Pharmaceuticals (CRNX) reported change in other assets of $7.02M in Q1 2026.
- How has Crinetics Pharmaceuticals's change in other assets changed year-over-year?
- Crinetics Pharmaceuticals's change in other assets increased by 1.5% year-over-year, from $6.92M to $7.02M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.